Search Results 5231-5240 of 16935 for mesenteric fat and ibd
-
There is a need for new treatments for myelofibrosis (MF) patients based on laboratory insight into disease pathogenesis. We will use primary patient samples to ...
-
About this study. The purpose of this study is to provide a survey to prospective candidates undergoing transcatheter valve replacement or repair at two ...
-
The purpose of this study is to evaluate the safety and clinical activity of one infusion of UCARTCS1A (t-cells) and to determine the Maximum Tolerated Dose ( ...
-
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
-
About this study. The purpose of this study is to to explain the mechanisms of brain resilience and susceptibility to post-stroke cognitive impairment and ...
-
Dabrafenib is a potent and selective inhibitor of BRAF kinase activity. This is a Phase II, non-randomized, open-label study to assess the efficacy, safety, and ...
-
About this study. This is a study to generate feasibilty data regarding the collection of health and psychosocial outcomes after acquired spinal cord injury ...
-
African Americans, Afro-Caribbeans, Hispanic Blacks, and Africans are more likely to have the APOL1 gene variants that cause kidney disease. APOLLO will test ...
-
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
-
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...